Ad hoc announcement pursuant to Art. 53 LR

Large clinical study of dental implants yields impressive 10-year outcomes

 

 
Basel, 12 December 2012 – New research findings have just been published from one of the largest long-term clinical studies on the survival and success of dental implants.

 

The study, which was conducted at the University of Bern in Switzerland, assessed the outcome of 511 Straumann SLA tissue-level implants in 303 patients over 10 years.

 

Its authors concluded: “The present retrospective analysis resulted in a 10-year implant survival rate of 98.8% and a success rate of 97.0%. In addition, the prevalence of peri-implantitis in this large cohort of orally healthy patients was low with 1.8% during the 10-year period”. No implant fracture was noted.

 

The importance of this study lies not only in the impressive long-term outcomes but also in the fact that it is one of the first large 10-year clinical studies to document a dental implant of this kind that is still on the market. The Straumann SLA tissue-level implant is indeed one of the most extensively studied dental implants and these long-term results explain why it is also one of the most widely used.

 

For details please see the attached release from the University of Bern and the full publication:

 

Buser D, Janner S, Wittneben J, Brägger U, Ramseier A, Salvi G: 10-Year Survival and Success Rates of 511 Titanium Implants with a Sandblasted and Acid-Etched Surface: A Retrospective Study in 303 Partially Edentulous Patients. Clinical Implant Dentistry and Related Research, Volume 14, Number 6, December 2012  DOI: 10.1111/j.1708-8208.2012.00456.x

 

At: http://onlinelibrary.wiley.com/doi/10.1111/j.1708-8208.2012.00456.x/full

 

 

About Straumann

Headquartered in Basel, Switzerland, the Straumann Group (SIX: STMN) is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs 2575 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.

 

 

 

Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland.

Phone: +41 (0)61 965 11 11 / Fax: +41 (0)61 965 11 01

E-mail: investor.relations@straumann.com or corporate.communication@straumann.com

Homepage: www.straumann.com

 

 

Contacts:

 

Corporate Communication:

Mark Hill              

+41 (0)61 965 13 21

 

Thomas Konrad

+41 (0)61 965 15 46

 

Investor Relations:

Fabian Hildbrand

+41 (0)61 965 13 27

 

Straumann Media Releases subscription:

www.straumann.com/en/home/investor-relations/ir-contacts-and-services/subscription.html

 

#  #  #

 

 

Downloads